Fundz

Who to call at Gain Therapeutics, Inc., and when

Fundz watches for the moments Gain Therapeutics, Inc. starts buying, and tells you who to reach.

  • An alert the day Gain Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gain Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gain Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

Gain Therapeutics, Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

gaintherapeutics.com
Filed: Oct 28, 2026Bethesda, MarylandCIK: 0001819411Health Care
Full company profileView on SEC.gov

2 executive changes at Gain Therapeutics in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

See every company with multiple executive changes →

Executive Summary

Analysis of 8-K filing content

Gain Therapeutics appointed Jeanette Weidner as Vice President of Finance effective October 28, 2026, with responsibility for principal financial and accounting officer duties. This executive hire strengthens the company's financial leadership with a seasoned life sciences finance professional.

Other companies that filed an 8-K Item 5.02 (Executive Change) the same week

Analyzed filings with the same item number within 7 days, from SEC EDGAR via Fundz.

  • LENZ Therapeutics, Inc. (October 28, 2026): LENZ Therapeutics' President and CEO Evert Schimmelpennink resigned effective December 1, 2026, with CFO Daniel Chevallard assuming interim leadership.
  • Compass Minerals International, Inc. (October 28, 2026): Compass Minerals appointed Brett Teuscher as Chief Accounting Officer on October 28, 2026, following Ashley Ward's resignation on October 23, 2026.
  • Radian Group Inc. (October 28, 2026): Radian Group Inc. appointed Daniel Kobell as Senior Executive Vice President and Chief Financial Officer on October 28, 2026, after he served as Interim CFO since February 2026.
  • Monroe Federal Bancorp, Inc. (October 28, 2026): Monroe Federal Bancorp appointed Charles G. Brown III as President and CEO effective October 26, 2026, succeeding Lewis R. Renollet who transitioned to Senior Executive Vice...
  • Techlott Inc. (October 28, 2026): Eldar Grady, Chairman and Executive Chairman of Techlott Inc., resigned from all positions effective October 28, 2026, under a separation agreement that terminates his consulting...
  • ABM Industries Incorporated (October 28, 2026): Rene Jacobsen, Executive Vice President and Chief Operating Officer of ABM Industries, announced his voluntary retirement effective February 1, 2027, with a transition to...

Key Takeaways

Jeanette Weidner brings 18 years of accounting and finance experience, including over a decade in life sciences (medical devices, regenerative medicine, biopharmaceuticals)

She will serve as both VP of Finance and principal financial/accounting officer, consolidating key financial leadership roles

3 more takeaways

Filing Overview

Form Type8-K
Filing DateOct 28, 2026
Item5.02
CategoryExecutive Change
CIK0001819411
Accession #0001104659-26-119673
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
executive hireleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Gain Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.